Cargando…
A brief review of the genetics and pharmacogenetics of opioid use disorders
Increased physician prescribing of opioids to treat chronic nonprogressive pain has been accompanied by an increase in opioid addiction. Twin studies of opioid addiction are consistent with an inherited component of risk, approximately 50%. Several genome-wide association study (GWAS) reports indica...
Autor principal: | Berrettini, Wade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741106/ https://www.ncbi.nlm.nih.gov/pubmed/29302220 |
Ejemplares similares
-
Molecular linkage studies of bipolar disorder
por: Berrettini, Wade H.
Publicado: (1999) -
Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder
por: Crist*, Richard. C., et al.
Publicado: (2018) -
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019) -
Pharmacogenetics of antiepileptic drugs: A brief review
por: Parker, D., et al.
Publicado: (2016) -
Genetic bases for endophenotypes in psychiatric disorders
por: Berrettini, Wade H.
Publicado: (2005)